Moxifloxacin Versus Ofloxacin Plus Metronidazole in Uncomplicated Pelvic Inflammatory Disease: Multicenter Randomized Controlled Trials
Launched by ISTANBUL BAKIRKOY MATERNITY AND CHILDREN DISEASES HOSPITAL · Feb 23, 2013
Trial Information
Current as of May 28, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women diagnosed uncomplicated PID
- • 2. Patients age are between 14 with 45
- • 3. Pelvic tenderness and vaginal discharge
- Exclusion Criteria:
- • 1. Urinary Tract Enfections
- • 2. Tubo-ovarian abscess and complicated PID
- • 3. Hıstory of antibiotics treatment
- • 4. Other pelvic pain causes
- • 5. Endometriosis
- • 6. Delivery,abortion and surgery within last months
About Istanbul Bakirkoy Maternity And Children Diseases Hospital
Istanbul Bakirkoy Maternity and Children Diseases Hospital is a leading healthcare institution dedicated to providing comprehensive maternal and pediatric care. With a strong emphasis on research and innovation, the hospital is committed to advancing medical knowledge through clinical trials that aim to improve patient outcomes and enhance healthcare practices. The facility is equipped with state-of-the-art technology and staffed by a team of experienced professionals who specialize in various aspects of maternal and child health. By participating in clinical research, the hospital strives to contribute valuable insights to the medical community while ensuring the highest standards of care for its patients.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Samatya, Fatih, Turkey
İstanbul, Kucukcekmece, Turkey
Mardin, , Turkey
şişli, , Turkey
Patients applied
Trial Officials
Kemal Gungorduk, md
Study Chair
T.C.S.B. Kanıni Sultan Suleyman Training Hospital
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials